A systems biology approach for the study of cumulative oncogenes with applications to the MAPK signal transduction pathway

Biophysical Chemistry

Volumn 119, Issue 1, 2006, Pages 49-60

  Pant, Dhruv K ^a   Ghosh, Avijit ^a  

^a DREXEL UNIVERSITY   (United States)

Author keywords

Cumulative mutations; ERK activation; MAPK signaling pathway; Oncogenes; Sensitivity analysis

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN;

ARTICLE; CELL CYCLE; ENZYME ACTIVATION; ENZYME REGULATION; GENE MUTATION; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; KINETICS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; NEOPLASMS; ONCOGENES; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

EID: 29444432499     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpc.2005.09.001     Document Type: Article

References (36)

1. D.K. Pant, and A. Ghosh Automated oncogene detection in complex protein networks, with applications to the MAPK signal transduction pathway Biophys. Chem. 113 2005 275 288
2. A.B. Vojtek, and C.J. Der Increasing complexity of the Ras signaling pathway J. Biol. Chem. 273 1998 19925 19928
3. W. Pierceall, L. Goldberg, M. Tainsky, T. Mukhopadhyay, and H. Ananthaswamy Ras gene mutation and amplification in human non-melanoma skin cancers Mol. Carcinog. 4 1991 196 202
4. K.-F. R., and D. C.J. The ras signal transduction pathway Cancer Metastasis Rev. 13 1994 67 89
5. W. Kolch Meaningful relationships: the regulation of the ras/raf/mek/erk pathway by protein interactions Biochem. J. 351 2000 289 305
6. J. Downward Targeting ras signaling pathways in cancer therapy Nat. Rev., Cancer 3 2003 11 22
7. T. Joneson, and D. Bar-Sagi Ras effectors and their role in mitogenesis and oncogenesis J. Mol. Med. 75 1997 587 593
8. J.L. Bos Ras oncogenes in human cancer: a review Cancer Res. 49 1989 4682 4689
9. U.S. Bhalla, and R. Iyengar Emergent properties of networks of biological signaling pathways Science 283 1999 381 387
10. B. Schoeberl, C. Eichler-Jonsson, E.D. Gilles, and G. Muller Computational modeling of the dynamics of the map kinase cascade activated by surface and internalized egf receptors Nat. Biotechnol. 20 2002 370 375
11. A. Astharigi, and D. Lauffenburger A computational study of feedback effects on signal dynamics in a mitogen-activated protein kinase (mapk) pathway model Biotechnol. Prog. 17 2001 227 239
12. D. Beaupre, and R. Kurzrock Ras inhibitors in hematologic cancers: biologic considerations and clinical applications Invest. New Drugs 17 1999 137 153
13. Y. Kloog, and A. Cox Ras inhibitors: potential for cancer therapeutics Mol. Med. Today 6 2000 398 402
14. T.B. Brunner, S.M. Hahn, A.K. Gupta, R.J. Muschel, W.G. McKenna, and E.J. Bernhard Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations Cancer Res. 63 2003 5656 5668
15. A.D. Cox, and C.J. Der Farnesyltransferase inhibitors: promises and realities Curr. Opin. Pharmacol. 2 2002 388 393
16. K.R. Loeb, and L.A. Loeb Significance of multiple mutations in cancer Carcinogenesis 21 2000 379 385
17. T.D. Gilmore Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-rel Oncogene 18 1999 6925 6937
18. H. Ogiso, R. Ishitani, O. Nureki, S. Fukai, M. Yamanaka, J. Kim, K. Saito, A. Sakamoto, M. Inoue, and S. Yokoyama Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains Cell 110 2002 775 787
19. U.S. Bhalla, P.T. Ram, and R. Iyengar Map kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network Science 297 2002 1018 1023
20. K. Scheffzek, M. Ahmadian, W. Kabsch, L. Wiesmuller, A. Lautwein, F. Schmitz, and A. Wittinghofer The ras-rasgap complex: structural basis for gtpase activation and its loss in oncogenic ras mutants Science 277 1997 333 338
21. D. Vlette, R. E-Raver, D. Buffe, C. Rmbaut, and J. Peres c-ki-ras gene amplification and malignant behavior in murine embryonal carcinoma cell lines Cancer Res. 47 1987 867 873
22. P.W. Atkins Physical Chemistry 3rd ed. 1986 Oxford Univ. Press Oxford
23. W.H. Press, S.A. Teukolsky, W.T. Vetterling, and B.P. Flannery Numerical Recipes in C++ 2002 Cambridge University Press UK
24. A.C. Bowden Metabolic control analysis in theory and practice Adv. Mol. Cell Biol. 11 1995 21 64
25. R. Heinrich, and T.A. Rapoport A linear steady state treatment of enzymatic chains. General properties, control and effector strength Eur. J. Biochem. 42 1974 89 95
26. H. Kacser, and J.A. Burns The control of flux Symp. Soc. Exp. Biol. 27 1973 65 104
27. D.A. Fell Metabolic control analysis: a survey of its theoretical and experimental development Biochem. J. 286 1992 313 330
28. C. Reder Metabolic control theory: a structural approach J. Theor. Biol. 135 1988 175 201
29. M. Cascante, L.G. Boros, B. Comin-Anduix, P. de Atauri, J.J. Centelles, and P.W.N. Lee Metabolic control analysis in drug discovery and disease Nat. Biotechnol. 20 2002 243 249
30. T. Hofer, and R. Heinrich A second order approach to metabolic control analysis J. Theor. Biol. 164 1993 85 102
31. V. Hatzimanikatis Nonlinear metabolic control analysis Metab. Eng. 1 1999 75 87
32. D. Ratnasinghe, J.M. Phang, and G.C. Yeh Differential expression and activity of phosphatases and protein kinases in adriamycin sensitive and resistant human breast cancer mcf-7 cells Int. J. Oncol. 13 1998 79 84
33. C.E. Rocheleau, R.M. Howard, A.P. Goldman, M.L. Volk, L.J. Grard, and M.V. Sundaram A lin-45 raf enhancer screen identifies eor-1, eor-2 and unusual alleles of ras pathway genes in Caenorhabditis elegans Genetics 161 2002 121 131
34. Z. Baharians, and A.H. Schonthal Reduction of ha-ras-induced cellular transformation by elevated express on of protein phosphatase type 2a Mol. Carcinog. 24 1999 246 254
35. W. Chen, R. Possemato, K.T. Campbell, C.A. Plattner, D.C. Pallas, and W.C. Hahn Identification of specific pp2a complexes involved in human cell transformation Cancer Cells 5 2004 127 136
36. A. Martinez, M. Vos, L. Guedez, G. Kaur, Z. Chen, M. Garayoa, R. Pio, T. Moody, W.G. Stetler-Stevenson, H.K. Kleinman, and F. Cuttitta The effects of adrenomedullin overexpression in breast tumor cells J. Nat. Cancer Inst. 94 2002 1226 1237